Cartalax dose range
The amounts people commonly use, from the low end to the high end, with syringe units, schedule and half-life. The 8 published studies are one click away.
Animal studies only Bioregulators Also called AED, Ala-Glu-Asp, T-31
Common use ranges
From user guides and clinic write-ups. No drug label exists, and no study has tested these amounts in people. Injected amounts disagree by about ten times, from 0.7 to 1.4 mg a day in one guide to 10 mg a day in another. Sources are community and vendor guides only. No approved label exists in any country we found, and the published research comes almost entirely from one Russian research group.
Sources disagree, or there are very few. The amounts below come from a small number of guides, and they do not line up well. Treat every number on this page as uncertain, and check each source yourself.
- Half-life
- Not measured in any published study
- How it is taken
- Shot under the skin (subcutaneous), or oral capsule
- How long people use it
- Sources split. One gives 10 to 20 day courses every 3 to 6 months. Another gives 1 to 3 month courses, repeated once a year.
- Mixing used for the units
- 20 mg vial + 2 mL water. 1 unit on a U-100 insulin syringe = 100 mcg.
Pick your vial size and how much water you add. The units below change to match.
20 mg vial + 2 mL water: 1 unit = 100 mcg
| Tier | Each dose | Syringe units20 mg vial + 2 mL water | How often | Schedule | Vial lastsat this tier |
|---|---|---|---|---|---|
| Starting [1] | 700 mcg | 7 units 0.07 mL | once a day | 0.7 mg under the skin once a day, the low end of a 0.7 to 1.4 mg range. | about 4 weeks |
| Typical [2] | 1.4 mg | 14 units 0.14 mL | once a day | 1.4 mg under the skin once a day, the top of the 0.7 to 1.4 mg range. | 14 days |
| Higher [3] | 10 mg | 100 units 1.00 mL | once a day | 10 mg under the skin once a day for 10 to 20 days. | 2 days |
| Oral Typical [4] | 100 mcg | Not a syringe dose | 2x a day | 100 to 200 mcg (1 to 2 capsules) by mouth, 1 to 2 times a day, with meals. | |
| Oral Higher [5] | 200 mcg | Not a syringe dose | 2x a day | 200 mcg (2 capsules) by mouth twice a day, with meals, the top of the oral range. |
Good to know
- Capsules are taken with meals.
- Oral strengths vary a lot by maker. Some packs list capsules, not milligrams, so the label on the box matters more than any range here.
Sources for these amounts
- Starting: Peptide DB, Cartalax
- Typical: Peptide DB, Cartalax
- Higher: Peptide Assistant, Cartalax
- Oral Typical: Peptide DB, Cartalax
- Oral Higher: Peptide DB, Cartalax
How long people use it: Peptide Assistant, Cartalax · Peptide DB, Cartalax · Khavinson bioregulator guide (IPS News)
Half-life: Khavinson et al 2022, transport of ultrashort peptides (no half-life data)
Take the Cartalax chart with you
Get a one-page printable chart for Cartalax, with the syringe units for each vial and water mix. We can also email you when a new Cartalax study is published.
This page shows what labels, clinics and users report, and what studies gave. It is not medical advice and not a recommendation for anyone. Many of these compounds are not approved for human use. Check your own medicines and lab work with a licensed clinician before using anything.
See the science: 8 published studies
No human dose data. No published human study of Cartalax states an amount given. Every figure on this page comes from animal studies.
Read this first. No PubMed abstract gives an in-animal amount. Stated figures are cell culture only: 0.01 µg/mL to 200 ng/ml in human stem cells. A Russian patent (not peer reviewed) describes knee arthrosis patients given 1 µg to 5 mg daily, with no PubMed record.
Every study used for this page
Proof grade: Animal studies only. No human dose data has been published. Amounts are quoted as each study reported them. Where the abstract does not state an amount, the row says so.
| Study | Who was studied | Amount given, as reported | Route | How often | How long | What the authors reported |
|---|---|---|---|---|---|---|
| PMID 18306703Povorozniuk et al, Adv Gerontol 2007 | Rat, ovariectomized osteoporosis model (n NOT IN ABSTRACT) | Not stated in the abstract | NOT IN ABSTRACT | NOT IN ABSTRACT | NOT IN ABSTRACT | Prevented and partly reversed bone density loss, cartilage extract worked better |
| PMID 30607912Zamorskii et al, Adv Gerontol 2018 | Rat, old (n NOT IN ABSTRACT) | Not stated in the abstract | NOT IN ABSTRACT | NOT IN ABSTRACT | NOT IN ABSTRACT | Raised urine output 1.2 to 1.4 times, cut urine protein 1.5 to 2.8 times |
| PMID 26515176Zamorskii et al, Bull Exp Biol Med 2015 | Rat, cisplatin kidney failure (n NOT IN ABSTRACT) | Not stated in the abstract | NOT IN ABSTRACT | NOT IN ABSTRACT | NOT IN ABSTRACT | Lowered urine protein and salt loss, weaker than EDL |
| PMID 37782646Myakisheva et al, Adv Gerontol 2023 | Human mesenchymal stem cells, aging passages | 200 ng/ml | Added to cell culture | NOT IN ABSTRACT | NOT IN ABSTRACT | Raised cartilage-forming genes and proteins (SOX9, aggrecan, collagen II, COMP) |
| PMID 30791821Caputi et al, Int J Immunopathol Pharmacol 2019 | Human periodontal ligament stem cells | 0.01 mcg/mL (PMC full text) | Added to cell culture | Replaced every 3 days | NOT IN ABSTRACT | AED alone did not stand out, the four-peptide mix and KED raised nerve markers |
| PMID 33231794Fridman et al, Bull Exp Biol Med 2020 | Human skin fibroblasts, replicative aging | Not stated in the abstract | Added to cell culture | NOT IN ABSTRACT | NOT IN ABSTRACT | Raised sirtuin-1, sirtuin-6 and collagen I |
| PMID 27259496Linkova et al, Bull Exp Biol Med 2016 | Skin fibroblast cultures, aging | Not stated in the abstract | Added to cell culture | NOT IN ABSTRACT | NOT IN ABSTRACT | Lowered MMP-9 and caspase-3, raised Ki-67 |
| PMID 32399807Ashapkin et al, Mol Biol Rep 2020 | Human fetal bone marrow stem cells (FetMSCs) | Not stated in the abstract | Added to cell culture | NOT IN ABSTRACT | NOT IN ABSTRACT | Raised IGF1 expression 3.5 to 5.6 fold with the peptides tested |
How to read the study numbers
- One study, one group. Each figure is what one team chose for its own participants or animals.
- Route matters. An amount given into a vein (IV) is not the same as the same amount under the skin, in the nose or by mouth.
- Animals are not small people. An animal amount is shown as the study gave it. It is not a human amount.
- Short studies. Many studies ran days or weeks. They do not show what happens over longer use.
Common questions
Is there a human dose for Cartalax?
No published human study of Cartalax states an amount given. The figures on this page come from animal studies only.
Where do these Cartalax numbers come from?
From 8 published studies, each linked to its PubMed or ClinicalTrials.gov record. Every figure was checked against the study abstract or its open full text. Proof grade: Animal studies only.
How long does Cartalax stay in the body?
No published study has measured the half-life of Cartalax, so nobody knows exactly how long one dose stays in the blood.
Is this a recommendation for how much Cartalax to use?
No. This page shows the amounts reported by drug labels, clinics and users, next to what researchers gave in studies. It is not medical advice and not a recommendation for anyone. Talk to a licensed clinician before using any of it.